Tool
Stock screener
Filter the 3753 large-cap US stocks StockVane tracks, then sort by any column. Results carry the same Quant Rating shown on each stock’s page.
Top Quant-ratedLarge-cap dividend payersCheap & top-ratedBeaten-down (down 20%+ 1yr)High yield (4%+)Mega-cap winners
177 matches
| Company | 60d | Last | Chg% | Mkt cap | P/E | Yield | 1-yr | Quant ↓ |
|---|---|---|---|---|---|---|---|---|
| ModernaMRNA | 196.48 | +4.81% | $78.44B | -- | -- | +603.7% | A 100 | |
| Praxis Precision MedicinesPRAX | 278.02 | -0.76% | $7.76B | -- | -- | +412.1% | D 100 | |
| Iovance BiotherapeuticsIOVA | 12.92 | -0.35% | $5.85B | -- | -- | +468.9% | A 100 | |
| Kodiak SciencesKOD | 91.08 | -1.36% | $5.72B | -- | -- | +529.9% | A 100 | |
| ErascaERAS | 14.12 | -1.26% | $4.94B | -- | -- | +481.1% | D 100 | |
| Sellas Life SciencesSLS | 11.31 | -0.26% | $2.28B | -- | -- | +486.0% | A 100 | |
| Damora TherapeuticsDMRA | 20.24 | +3.53% | $1.25B | -- | -- | +90.0% | D 100 | |
| Revolution MedicinesRVMD | 200.87 | +0.50% | $43.05B | -- | -- | +320.1% | B 99 | |
| Twist BioscienceTWST | 155.65 | -6.78% | $10.32B | -- | -- | +374.7% | B 99 | |
| ImmunityBioIBRX | 9.75 | +0.62% | $10.33B | -- | -- | +285.4% | B 99 | |
| Spyre TherapeuticsSYRE | 80.85 | +0.92% | $7.13B | -- | -- | +357.3% | B 99 | |
| MBX BiosciencesMBX | 54.54 | -4.18% | $2.63B | -- | -- | +243.9% | B 99 | |
| OmerosOMER | 18.75 | +1.30% | $1.36B | 10.84 | -- | +327.1% | B 99 | |
| Relay TherapeuticsRLAY | 17.95 | -4.22% | $3.93B | -- | -- | +193.8% | B 98 | |
| Tango TherapeuticsTNGX | 21.83 | -0.32% | $3.68B | -- | -- | +215.9% | B 98 | |
| ReplimuneREPL | 13.20 | -0.38% | $1.24B | -- | -- | +188.8% | B 98 | |
| Dianthus TherapeuticsDNTH | 84.88 | -0.61% | $4.75B | -- | -- | +144.3% | B 97 | |
| Absci CorpABSI | 9.22 | -10.22% | $1.58B | -- | -- | +120.6% | B 97 | |
| Inhibrx BiosciencesINBX | 93.36 | -0.05% | $1.37B | -- | -- | +177.8% | B 97 | |
| Protagonist TherapeuticsPTGX | 140.92 | +1.61% | $9.12B | 136.82 | -- | +115.8% | B 96 | |
| PrecigenPGEN | 7.54 | -0.13% | $2.70B | -- | -- | +134.2% | B 96 | |
| Nurix TherapeuticsNRIX | 22.73 | +0.58% | $2.36B | -- | -- | +127.8% | B 96 | |
| UroGen Pharma LtdURGN | 40.70 | -1.76% | $1.99B | -- | -- | +134.9% | B 96 | |
| Maravai LifeSciencesMRVI | 7.43 | -5.35% | $1.11B | -- | -- | +123.1% | B 96 | |
| Fortrea HoldingsFTRE | 20.56 | -1.06% | $1.96B | -- | -- | +103.0% | B 95 | |
| Travere TherapeuticTVTX | 53.44 | -4.54% | $5.04B | -- | -- | +104.0% | B 94 | |
| Vir BiotechnologyVIR | 11.52 | -0.69% | $1.95B | -- | -- | +90.4% | B 94 | |
| XencorXNCR | 24.26 | -0.41% | $1.80B | -- | -- | +95.6% | B 94 | |
| ImmunovantIMVT | 32.04 | -0.22% | $6.62B | -- | -- | +99.3% | B 93 | |
| Shattuck LabsSTTK | 5.66 | -3.50% | $567.55M | -- | -- | +136.6% | A 92 | |
| Kymera TherapeuticsKYMR | 108.35 | +2.24% | $9.01B | -- | -- | +92.5% | B 92 | |
| Cogent BiosciencesCOGT | 30.14 | -0.79% | $5.23B | -- | -- | +93.5% | D 92 | |
| Korsana BiosciencesKRSA | 31.65 | -0.38% | $1.97B | -- | -- | +79.4% | B 92 | |
| Krystal BiotechKRYS | 324.57 | -0.69% | $9.61B | 40.67 | -- | +73.4% | B 91 | |
| Arcus BiosciencesRCUS | 24.52 | +0.99% | $3.12B | -- | -- | +62.9% | D 89 | |
| Jazz PharmaceuticalsJAZZ | 231.19 | -0.09% | $15.01B | 15.82 | -- | +67.8% | B 88 | |
| VaxcytePCVX | 66.96 | +0.39% | $9.96B | -- | -- | +64.4% | B 87 | |
| Arrowhead PharmaceuticalsARWR | 61.48 | -0.10% | $8.68B | -- | -- | +66.4% | D 87 | |
| CG OncologyCGON | 62.38 | -1.98% | $5.53B | -- | -- | +53.2% | D 87 | |
| GH ResearchGHRS | 21.06 | -2.14% | $1.45B | -- | -- | +59.9% | D 87 | |
| Ligand PharmaceuticalsLGND | 293.26 | -1.24% | $5.85B | 30.20 | -- | +59.0% | B 86 | |
| Immix BiopharmaIMMX | 9.49 | -1.56% | $788.42M | -- | -- | +273.6% | B 82 | |
| Harmony BiosciencesHRMY | 39.34 | -0.05% | $2.29B | 12.73 | -- | +48.1% | B 82 | |
| ExelixisEXEL | 58.44 | +0.19% | $14.48B | 18.38 | -- | +51.2% | B 81 | |
| Axsome TherapeuticsAXSM | 172.97 | -0.79% | $9.06B | -- | -- | +45.7% | D 80 | |
| TG TherapeuticsTGTX | 52.95 | +1.46% | $8.11B | 19.32 | -- | +48.1% | B 80 | |
| Aclaris TherapeuticsACRS | 3.40 | -8.11% | $500.48M | -- | -- | +78.9% | B 79 | |
| Eupraxia PharmaceuticalsEPRX | 7.78 | +0.52% | $514.05M | -- | -- | +26.7% | B 79 | |
| Obsidian TherapeuticsOBX | 13.20 | -0.15% | $815.40M | 20.31 | -- | -- | B 79 | |
| Aurinia PharmaceuticalsAUPH | 16.01 | +2.04% | $2.13B | 7.02 | -- | +38.9% | B 79 | |
| VerastemVSTM | 8.27 | +6.65% | $748.51M | -- | -- | -7.5% | B 77 | |
| CelcuityCELC | 65.78 | -7.68% | $3.22B | -- | -- | +32.9% | D 77 | |
| PharvarisPHVS | 31.68 | +1.80% | $2.22B | -- | -- | +37.9% | B 76 | |
| Alto NeuroscienceANRO | 23.52 | -0.72% | $922.97M | -- | -- | +278.7% | B 75 | |
| ApnimedAPMD | 18.04 | -3.27% | $751.02M | 4.63 | -- | -- | B 75 | |
| CybinHELP | 10.51 | -2.32% | $767.86M | -- | -- | +67.9% | B 75 | |
| Nuvectis PharmaNVCT | 20.29 | +1.30% | $662.35M | -- | -- | +225.7% | B 75 | |
| 4D Molecular TherapeuticsFDMT | 12.59 | +0.24% | $695.52M | -- | -- | +30.3% | B 74 | |
| Corcept TherapeuticsCORT | 119.60 | +0.03% | $12.93B | 265.78 | -- | +35.2% | B 74 | |
| Adlai Nortye GroupANL | 14.05 | -2.84% | $904.79M | -- | -- | +712.1% | B 73 |
Reference only, not investment advice. A screen is a starting point, not a buy list. Quant Rating method: Data & Methodology.